| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a6a9431aa1fe5109ca95ad4e332231b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22 |
| filingDate |
1983-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1154fa748faed74344d605c311dfb35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4830c1ca5f6aa31d151f0ca5abc97d78 |
| publicationDate |
1983-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-8303354-A1 |
| titleOfInvention |
Neisseria gonorrhoeae vaccine |
| abstract |
A highly antigenic vaccine containing one or more protein I serotypes and protecting humans against infection by Neisseria gonorrhoeae microorganisms (gonococci) is obtained by a process for the preparation of highly purified and high concentration serotypes, resulting in increased solubility of protein I serotypes |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5736361-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0351604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0395706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6348332-B1 |
| priorityDate |
1982-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |